Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uveal Melanoma × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

Ipilimumab 5 pembrolizumab 4 Nivolumab 4 Dacarbazine 4 CTLA-4 Antigen 3 aflibercept 2 Temozolomide 2 Ranibizumab 2 Radiosurgery 2 Paclitaxel 2 Lenalidomide 2 Cyclophosphamide 2 Carboplatin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 utomilumab 1 ulixertinib 1 trametinib 1 tebentafusp 1 sotrastaurin 1 sargramostim 1 relatlimab 1 poly ICLC 1 pasireotide 1 omipalisib 1 oblimersen 1 niraparib 1 lenvatinib 1 glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡